Atrium Therapeutics Inc (RNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Assets | ||||
| Current Assets | ||||
| Other current assets | 1,230 | 1,230 | 1,940 | 2,110 |
| TOTAL | $1,230 | $1,230 | $1,940 | $2,110 |
| Non-Current Assets | ||||
| Other Non-Current Assets | 1,360 | 1,380 | 1,740 | 1,780 |
| TOTAL | $1,360 | $1,380 | $1,740 | $1,780 |
| Total Assets | $2,590 | $2,610 | $3,680 | $3,890 |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | 260 | 250 | 0 | 0 |
| Accounts payable and accrued liabilities | 7,690 | 6,840 | 8,230 | 10,260 |
| Other current liabilities | 20 | 4,960 | 9,310 | 9,590 |
| TOTAL | $7,970 | $12,050 | $17,950 | $20,260 |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 20 | 20 | 30 | 30 |
| TOTAL | $140 | $14,430 | $12,030 | $13,170 |
| Total Liabilities | $8,110 | $26,480 | $29,980 | $33,430 |
| Shareholders' Equity | ||||
| Common Shares | 490 | 470 | 470 | 370 |
| Other shareholders' equity | 3,480 | 2,810 | -14,170 | -8,890 |
| TOTAL | $167,420 | $161,640 | $144,170 | $64,760 |
| Total Liabilities And Equity | $175,530 | $188,120 | $174,150 | $98,190 |